Seeking Alpha

MedGuy103

MedGuy103
Send Message
View as an RSS Feed
View MedGuy103's Comments BY TICKER:
Latest  |  Highest rated
  • Tonix Pharmaceuticals: Four Data-Based Valuations Of A Deeply Underappreciated Pharmaceutical Company [View article]
    That's another problem with TNX, it won't take very long to develop and test a competitor. I'm guessing within 5 years if the market was even desirable, which I'm guessing it won't be.
    Apr 25, 2015. 02:33 PM | Likes Like |Link to Comment
  • Some Questions For Dr. Scarlett, CEO Of Geron [View article]
    Very good sign.
    Apr 25, 2015. 08:28 AM | Likes Like |Link to Comment
  • Some Questions For Dr. Scarlett, CEO Of Geron [View article]
    Well that's the magic word then "primary". How is that defined and when does "primary" data become available? Being CR/PRs are seen typically within 3 months, wouldn't "primary" data be available this year?
    Apr 25, 2015. 08:27 AM | 3 Likes Like |Link to Comment
  • NovaBay Pharmaceuticals Seeks To Change The Paradigm Of Eye Care From Practitioner To Patient [View article]
    Sully, please read more carefully, the registration is for insiders to sell, not buy. There is too much misinformation and glee regarding a major stakeholder and business partner bailing on the company. From the S-3 you can find here: http://tinyurl.com/oj5...
    Look at the huge list of insider selling (15 and only 4 have any shares left after the sale). The largest seller is Pioneer. I don't know who is lying to you, but you need to look at the source for facts. Page 4 of the S-3 shows all the insiders selling. Board member Mark M. Sieczkarek is selling 94% of his shares (458,331) and you people are buying? Lots of luck.
    Apr 25, 2015. 08:19 AM | Likes Like |Link to Comment
  • Some Questions For Dr. Scarlett, CEO Of Geron [View article]
    I agree with you del, but it does have the added benefit of lowering toxicity threshold for the study.
    Apr 24, 2015. 09:20 PM | Likes Like |Link to Comment
  • NovaBay Pharmaceuticals Seeks To Change The Paradigm Of Eye Care From Practitioner To Patient [View article]
    You haven't read the S-3 registration. Pioneer is selling ALL their stock and it is being shopped now.
    Apr 24, 2015. 08:59 PM | Likes Like |Link to Comment
  • Got Alpha. Now What? A New Way To Kill Spiders (SPY) [View article]
    Not exactly fair to label Buffet as an "active" investment manager. Compared to most active managers, Buffet is more of an index.
    Apr 24, 2015. 07:10 AM | 1 Like Like |Link to Comment
  • Some Questions For Dr. Scarlett, CEO Of Geron [View article]
    Recalculate. It's not even up 300% from the 52 week lows, and I know it was over $1 when you mentioned it. Still, happy for you as it is making new highs. That doesn't mean you didn't have substantial risk.
    Apr 24, 2015. 03:33 AM | Likes Like |Link to Comment
  • Some Questions For Dr. Scarlett, CEO Of Geron [View article]
    You're such a tease!
    Apr 23, 2015. 10:17 PM | Likes Like |Link to Comment
  • NovaBay Pharmaceuticals Seeks To Change The Paradigm Of Eye Care From Practitioner To Patient [View article]
    Pioneer is bailing their shares and warrants, not a lot of confidence in Neutrophase.
    Apr 22, 2015. 08:30 PM | Likes Like |Link to Comment
  • Some Questions For Dr. Scarlett, CEO Of Geron [View article]
    I was just "bustin' stones" as they say.
    Apr 22, 2015. 08:56 AM | Likes Like |Link to Comment
  • Some Questions For Dr. Scarlett, CEO Of Geron [View article]
    I can't believe I waited 2 minutes just to read this post...
    Apr 22, 2015. 12:12 AM | Likes Like |Link to Comment
  • NovaBay Pharmaceuticals Seeks To Change The Paradigm Of Eye Care From Practitioner To Patient [View article]
    Unlikely, Pioneer is selling their shares in the secondary that was registered earlier this month. Price drop is likely firms running the secondary are shorting and will buy the Pioneer shares to cover the shorts. Secondary should happen before the end of the month.
    Apr 21, 2015. 11:46 PM | Likes Like |Link to Comment
  • NovaBay Pharmaceuticals Seeks To Change The Paradigm Of Eye Care From Practitioner To Patient [View article]
    Any chance you can do a followup question with CEO and ask why Pioneer Pharma is bailing on the company?
    Apr 21, 2015. 11:22 PM | Likes Like |Link to Comment
  • Tonix Pharmaceuticals: Four Data-Based Valuations Of A Deeply Underappreciated Pharmaceutical Company [View article]
    being
    Apr 21, 2015. 10:53 PM | 1 Like Like |Link to Comment
COMMENTS STATS
1,333 Comments
1,443 Likes